These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 15492291)

  • 1. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer.
    Yu C; Zhou Y; Miao X; Xiong P; Tan W; Lin D
    Cancer Res; 2004 Oct; 64(20):7622-8. PubMed ID: 15492291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional haplotypes in the promoter of matrix metalloproteinase-2 and lung cancer susceptibility.
    Zhou Y; Yu C; Miao X; Wang Y; Tan W; Sun T; Zhang X; Xiong P; Lin D
    Carcinogenesis; 2005 Jun; 26(6):1117-21. PubMed ID: 15731163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer.
    Zhang X; Miao X; Tan W; Ning B; Liu Z; Hong Y; Song W; Guo Y; Zhang X; Shen Y; Qiang B; Kadlubar FF; Lin D
    Gastroenterology; 2005 Aug; 129(2):565-76. PubMed ID: 16083713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma.
    Zhou G; Zhai Y; Cui Y; Qiu W; Yang H; Zhang X; Dong X; He Y; Yao K; Zhang H; Peng Y; Yuan X; Zhi L; Zhang X; He F
    Hum Mutat; 2007 Nov; 28(11):1091-7. PubMed ID: 17607721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease.
    Vasků A; Goldbergová M; Izakovicová Hollá L; Sisková L; Groch L; Beránek M; Tschöplová S; Znojil V; Vácha J
    Matrix Biol; 2004 Jan; 22(7):585-91. PubMed ID: 14996438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.
    Rollin J; Régina S; Vourc'h P; Iochmann S; Bléchet C; Reverdiau P; Gruel Y
    Lung Cancer; 2007 May; 56(2):273-80. PubMed ID: 17208328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
    Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer.
    O-Charoenrat P; Khantapura P
    Oral Oncol; 2006 Mar; 42(3):257-67. PubMed ID: 16275157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional genotype in matrix metalloproteinases-2 promoter is a risk factor for oral carcinogenesis.
    Lin SC; Lo SS; Liu CJ; Chung MY; Huang JW; Chang KW
    J Oral Pathol Med; 2004 Aug; 33(7):405-9. PubMed ID: 15250832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-18 gene promoter polymorphisms and the risk of esophageal squamous cell carcinoma.
    Wei YS; Lan Y; Liu YG; Tang H; Tang RG; Wang JC
    Acta Oncol; 2007; 46(8):1090-6. PubMed ID: 17851835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer.
    Xu E; Lai M; Lv B; Xing X; Huang Q; Xia X
    Biochem Biophys Res Commun; 2004 Nov; 324(3):999-1003. PubMed ID: 15485653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.
    Zhang J; Jin X; Fang S; Wang R; Li Y; Wang N; Guo W; Wang Y; Wen D; Wei L; Dong Z; Kuang G
    Carcinogenesis; 2005 Oct; 26(10):1748-53. PubMed ID: 15930031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional -1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is associated with the risk for oral squamous cell carcinoma in younger male areca users.
    Tu HF; Wu CH; Kao SY; Liu CJ; Liu TY; Lui MT
    J Oral Pathol Med; 2007 Aug; 36(7):409-14. PubMed ID: 17617834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.
    Zinzindohoué F; Blons H; Hans S; Loriot MA; Houllier AM; Brasnu D; Laccourreye O; Tregouet DA; Stucker I; Laurent-Puig P
    Anticancer Res; 2004; 24(3b):2021-6. PubMed ID: 15274394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer.
    Hao B; Miao X; Li Y; Zhang X; Sun T; Liang G; Zhao Y; Zhou Y; Wang H; Chen X; Zhang L; Tan W; Wei Q; Lin D; He F
    Oncogene; 2006 Jun; 25(25):3613-20. PubMed ID: 16652158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variation in transforming growth factor-beta1 gene associated with increased risk of esophageal squamous cell carcinoma.
    Wei YS; Xu QQ; Wang CF; Pan Y; Liang F; Long XK
    Tissue Antigens; 2007 Dec; 70(6):464-9. PubMed ID: 17990985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
    Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
    Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma.
    Zhang J; Jin X; Fang S; Li Y; Wang R; Guo W; Wang N; Wang Y; Wen D; Wei L; Kuang G; Dong Z
    Carcinogenesis; 2004 Dec; 25(12):2519-24. PubMed ID: 15319302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methyl-CpG binding domain 1 gene polymorphisms and risk of primary lung cancer.
    Jang JS; Lee SJ; Choi JE; Cha SI; Lee EB; Park TI; Kim CH; Lee WK; Kam S; Choi JY; Kang YM; Park RW; Kim IS; Cho YL; Jung TH; Han SB; Park JY
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2474-80. PubMed ID: 16284366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squmaous cell carcinoma.
    Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B
    Mutat Res; 2009 Apr; 663(1-2):52-9. PubMed ID: 19428370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.